FindTrial
Sign In

The Clinical Link Between Biologic Agents and Postoperative Venous Thromboembolism in Crohn's Disease: An Overlooked Detail

Development and Validation of Explainable Machine Learning-Based Predictive Models for Assessing Abdominal Surgery Risk, Postoperative Endoscopic Recurrence, and Biologic Therapy Efficacy in Crohn’s Disease Patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500105092
Enrollment
Unknown
Registered
2025-06-29
Start date
2025-06-29
Completion date
Unknown
Last updated
2025-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Crohn’s disease

Interventions

Case series :None

Sponsors

The Second Xiangya Hospital of Central South University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 200 Years

Inclusion criteria

Inclusion criteria: 1.Patients diagnosed with Crohn’s disease according to the current IBD diagnosis and treatment guidelines; 2.Initial diagnosis made at The Second XiangyaHospital of Central South University.

Exclusion criteria

Exclusion criteria: 1.Patients who have undergone abdominal intestinal resection surgery (excluding appendectomy) prior to diagnosis or treatment at our hospital; 2.Clinical data missing more than 20%; 3.Missing follow-up information; 4.Death due to other diseases or natural causes.

Design outcomes

Secondary

MeasureTime frame
Postoperative endoscopic recurrence after abdominal surgery;—

Primary

MeasureTime frame
First-time abdominal surgery;—

Countries

China

Contacts

Public ContactLianwen Yuan

The Second Xiangya Hospital of Central South University

yuanlianwen@csu.edu.cn+86 731 8529 5267

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026